Deutsch English Français

Contact

EP1292712

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1292712

EP1292712 - MEANS AND METHODS FOR MONITORING ANTIRETROVIRAL THERAPY AND GUIDING THERAPEUTIC DECISIONS IN THE TREATMENT OF HIV/AIDS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 08.05.2009 Database last updated on 28.06.2024
Most recent event Tooltip	08.05.2009	Application deemed to be withdrawn	published on 10.06.2009 [2009/24]
Applicant(s)	For all designated states Monogram BioSciences, Inc. 345 Oyster Point Boulevard South San Francisco, CA 94080-1913 / US
	[N/P]
Former [2006/32]	For all designated states Monogram Biosciences, Inc. 345 Oyster Point Boulevard South San Francisco, CA 94080-1913 / US
Former [2003/12]	For all designated states Virologic, Inc. 270 East Grand Avenue South San Francisco, CA 94080 / US
Inventor(s)	01 / WHITCOMB, Jeannette 2260 Cobblehill Place San Mateo, CA 94402 / US
	[2003/12]
Representative(s)	Tollervey, Rebecca Marie, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB
	[N/P]
Former [2009/23]	Tollervey, Rebecca Marie, et al Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS / GB
Former [2006/22]	Hodsdon, Stephen James Mewburn Ellis LLP York House 23 Kingway London WC2B 6HP / GB
Former [2006/15]	Ricker, Mathias, et al Jones Day, Rechtsanwälte, Attorneys-at-Law, Patentanwälte, Prinzregentenstrasse 11 80538 München / DE
Former [2003/12]	Denison, Christopher Marcus Mewburn Ellis York House 23 Kingsway London WC2B 6HP / GB
Application number, filing date	01944452.0	12.06.2001
	[2003/12]
	WO2001US18882
Priority number, date	US20000591894	12.06.2000 Original published format: US 591894
	[2003/12]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO0196611
	Date:	20.12.2001
	Language:	EN
	[2001/51]
	Type:	A1 Application with search report
	No.:	EP1292712
	Date:	19.03.2003
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 20.12.2001 takes the place of the publication of the European patent application.
	[2003/12]
Search report(s)	International search report - published on:	US	20.12.2001
	(Supplementary) European search report - dispatched on:	EP	07.03.2005
Classification	IPC:	C12Q1/70	[2003/12]
	CPC:	C12N15/86 (EP); A61P31/18 (EP); C07K14/005 (EP); C12Q1/703 (EP); C12N2740/16043 (EP); C12N2740/16122 (EP)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/12]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	VORRICHTUNGEN UND METHODEN ZUR UEBERWACHUNG VON ANTIRETROVIRALER THERAPIE UND ZUR HINFÜHRUNG ZU THERAPEUTISCHEN ENTSCHEIDUNGEN BEI DER BEHANDLUNG VON HIV/AIDS	[2003/12]
	English:	MEANS AND METHODS FOR MONITORING ANTIRETROVIRAL THERAPY AND GUIDING THERAPEUTIC DECISIONS IN THE TREATMENT OF HIV/AIDS	[2003/12]
	French:	SYSTEMES ET PROCEDES POUR LE CONTROLE DE THERAPIE ANTIRETROVIRALE ET L'ORIENTATION DES DECISIONS THERAPEUTIQUES DANS LE TRAITEMENT DU VIH/SIDA	[2003/12]
Entry into regional phase	06.01.2003	National basic fee paid
	06.01.2003	Search fee paid
	06.01.2003	Designation fee(s) paid
	06.01.2003	Examination fee paid
Examination procedure	09.01.2002	Request for preliminary examination filed International Preliminary Examining Authority: US
	06.01.2003	Examination requested [2003/12]
	26.02.2003	Amendment by applicant (claims and/or description)
	24.10.2005	Despatch of a communication from the examining division (Time limit: M06)
	15.08.2006	Reply to a communication from the examining division
	14.05.2007	Despatch of a communication from the examining division (Time limit: M06)
	23.11.2007	Reply to a communication from the examining division
	26.05.2008	Despatch of a communication from the examining division (Time limit: M06)
	06.12.2008	Application deemed to be withdrawn, date of legal effect [2009/24]
	14.01.2009	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2009/24]
Request for further processing for:	15.08.2006	Request for further processing filed
	15.08.2006	Full payment received (date of receipt of payment) Request granted
	31.08.2006	Decision despatched
Fees paid	Renewal fee
	12.06.2003	Renewal fee patent year 03
	14.06.2004	Renewal fee patent year 04
	14.06.2005	Renewal fee patent year 05
	14.06.2006	Renewal fee patent year 06
	27.07.2007	Renewal fee patent year 07
	25.06.2008	Renewal fee patent year 08
	Penalty fee
	Additional fee for renewal fee
	30.06.2007	07 M06 Fee paid on 27.07.2007
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[Y]WO9727332 (INNOGENETICS NV [BE], et al) [Y] 1-6 * page 4, line 15 - page 5, line 11; table 2 *;
		[Y]WO9727480 (VIRCO NV [BE], et al) [Y] 1-6 * claim 1; table 9 * * page 1, line 13 - page 2, line 17 *;
		[X]WO9961658 (VIROLOGIC INC [US]) [X] 1-6 * examples 6,7,10-14,16-18; claims 1-72 *;
		[Y] - CLERCQ DE E, "DEVELOPMENT OF RESISTANCE OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) TO ANTI-HIV AGENTS: HOW TO PREVENT THE PROBLEM?", INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, AMSTERDAM, NL, (1997), vol. 9, no. 1, ISSN 0924-8579, pages 21 - 36, XP000878561 [Y] 1-6 * the whole document * DOI: http://dx.doi.org/10.1016/S0924-8579(97)00031-9
		[Y] - SALOMON H ET AL, "Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study.", AIDS (LONDON, ENGLAND) 28 JAN 2000, (20000128), vol. 14, no. 2, ISSN 0269-9370, pages F17 - F23, XP008037438 [Y] 1-6 * the whole document * DOI: http://dx.doi.org/10.1097/00002030-200001280-00003
		[Y] - MELLORS J W ET AL, "MUTATIONS IN HIV-1 REVERSE TRANSCRIPTASE AND PROTEASE ASSOCIATED WITH DRUG RESISTANCE", INTERNATIONAL ANTIVIRAL NEWS, CHURCHILL LIVINGSTONE, EDINBURGH, GB, (1995), vol. 3, ISSN 0965-2310, pages 8 - 13, XP000614717 [Y] 1-6 * the whole document *
		[Y] - HOLODNIY M ET AL, "Determination of human immunodeficiency virus RNA in plasma and cellular viral DNA genotypic zidovudine resistance and viral load during zidovudine-didanosine combination therapy.", JOURNAL OF VIROLOGY. JUN 1995, (199506), vol. 69, no. 6, ISSN 0022-538X, pages 3510 - 3516, XP002317435 [Y] 1-6 * the whole document *
		[Y] - PELEMANS H ET AL, "CHARACTERISTICS OF THE PRO225HIS MUTATION IN HUMAN IMMUNODEFICIENCYVIRUS TYPE 1 (HIV-1) REVERSE TRANSCRIPTASE THAT APPEARS UNDER SELECTIVE PRESSURE OF DOSE-ESCALATING QUINOXALINE TREATMENT OF HIV-1", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (199711), vol. 71, no. 11, ISSN 0022-538X, pages 8195 - 8203, XP000885693 [Y] 1-6 * the whole document *
		[A] - KANKI P J ET AL, "VIROLOGY OF HIV-1 AND HIV-2: IMPLICATIONS FOR AFRICA", AIDS, LONDON, GB, (1997), vol. 11, no. SUPPL B, ISSN 0269-9370, pages S33 - S42, XP008035289 [A] 1-6 * the whole document * DOI: http://dx.doi.org/10.1097/00002030-199701000-00006
	International search	[A]US5917033 (MODAK MUKUND J [US], et al)

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p